Geneva, June 16 -- International Clinical Trials Registry received information related to the study (NCT07005947) titled 'Long COVID Cutaneous Signatures: An ARPA Funded Research Project' on June 3.
Study Type: Observational
Primary Sponsor: CND Life Sciences
Condition:
Long COVID
Acute COVID-19
Postural Orthostatic Tachycardia Syndrome (POTS)
Diabetic Neuropathy
Recruitment Status: Recruiting
Date of First Enrollment: November 30, 2023
Target Sample Size: 300
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07005947
Published by HT Digital Content Services with permission from Health Daily Digest....